These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36528009)

  • 1. The potential of intravenous topiramate for the treatment of status epilepticus.
    Löscher W; Trinka E
    Epilepsy Behav; 2023 Jan; 138():109032. PubMed ID: 36528009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical pharmacokinetics and tolerability of a novel meglumine-based parenteral solution of topiramate and topiramate combinations for treatment of status epilepticus.
    Rundfeldt C; Klein P; Boison D; Rotenberg A; D'Ambrosio R; Eastman C; Purnell B; Murugan M; Goodkin HP; Löscher W
    Epilepsia; 2023 Apr; 64(4):888-899. PubMed ID: 36708090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous topiramate for seizure emergencies - First in human case report.
    Apostolakopoulou L; Bosque Varela P; Rossini F; O'Sullivan C; Löscher W; Kuchukhidze G; Trinka E
    Epilepsy Behav; 2023 May; 142():109158. PubMed ID: 37058860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of topiramate in adult refractory status epilepticus: experience of a tertiary care center.
    Synowiec AS; Yandora KA; Yenugadhati V; Valeriano JP; Schramke CJ; Kelly KM
    Epilepsy Res; 2012 Feb; 98(2-3):232-7. PubMed ID: 22000869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of refractory and superrefractory status epilepticus with topiramate: A cohort study of 106 patients and a review of the literature.
    Fechner A; Hubert K; Jahnke K; Knake S; Konczalla J; Menzler K; Ronellenfitsch MW; Rosenow F; Strzelczyk A
    Epilepsia; 2019 Dec; 60(12):2448-2458. PubMed ID: 31713232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topiramate in the Treatment of Generalized Convulsive Status Epilepticus in Adults: A Systematic Review with Individual Patient Data Analysis.
    Brigo F; Bragazzi NL; Igwe SC; Nardone R; Trinka E
    Drugs; 2017 Jan; 77(1):67-74. PubMed ID: 28004305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of topiramate in children with refractory status epilepticus.
    Kahriman M; Minecan D; Kutluay E; Selwa L; Beydoun A
    Epilepsia; 2003 Oct; 44(10):1353-6. PubMed ID: 14510830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topiramate as an adjunctive treatment in patients with refractory status epilepticus: an observational cohort study.
    Hottinger A; Sutter R; Marsch S; Rüegg S
    CNS Drugs; 2012 Sep; 26(9):761-72. PubMed ID: 22823481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topiramate loading for refractory status epilepticus in children.
    Perry MS; Holt PJ; Sladky JT
    Epilepsia; 2006 Jun; 47(6):1070-1. PubMed ID: 16822255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of refractory generalized convulsive status epilepticus with enteral topiramate in resource limited settings.
    Asadi-Pooya AA; Jahromi MJ; Izadi S; Emami Y
    Seizure; 2015 Jan; 24():114-7. PubMed ID: 25458103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the value of topiramate in refractory status epilepticus.
    Madžar D; Kuramatsu JB; Gerner ST; Huttner HB
    Seizure; 2016 May; 38():7-10. PubMed ID: 27039016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of multidrug resistance gene and topiramate affect expression of multidrug resistance gene in the hippocampus of spontaneous epileptic rats].
    Jin RF; Sun RP; Xu XP
    Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):733-7. PubMed ID: 16255849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of pediatric refractory status epilepticus with topiramate.
    Akyildiz BN; Kumandaş S
    Childs Nerv Syst; 2011 Sep; 27(9):1425-30. PubMed ID: 21442269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early polytherapy for benzodiazepine-refractory status epilepticus.
    Niquet J; Lumley L; Baldwin R; Rossetti F; Schultz M; de Araujo Furtado M; Suchomelova L; Naylor D; Franco-Estrada I; Wasterlain CG
    Epilepsy Behav; 2019 Dec; 101(Pt B):106367. PubMed ID: 31636007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous topiramate: comparison of pharmacokinetics and safety with the oral formulation in healthy volunteers.
    Clark AM; Kriel RL; Leppik IE; Marino SE; Mishra U; Brundage RC; Cloyd JC
    Epilepsia; 2013 Jun; 54(6):1099-105. PubMed ID: 23506041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of topiramate in refractory status epilepticus.
    Towne AR; Garnett LK; Waterhouse EJ; Morton LD; DeLorenzo RJ
    Neurology; 2003 Jan; 60(2):332-4. PubMed ID: 12552056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral topiramate as an add-on treatment for refractory status epilepticus.
    Stojanova V; Rossetti AO
    Acta Neurol Scand; 2012 Feb; 125(2):e7-e11. PubMed ID: 21711264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topiramate and metabolic acidosis in pediatric epilepsy.
    Takeoka M; Holmes GL; Thiele E; Bourgeois BF; Helmers SL; Duffy FH; Riviello JJ
    Epilepsia; 2001 Mar; 42(3):387-92. PubMed ID: 11442157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergism between topiramate and budipine in refractory status epilepticus in the rat.
    Fisher A; Wang X; Cock HR; Thom M; Patsalos PN; Walker MC
    Epilepsia; 2004 Nov; 45(11):1300-7. PubMed ID: 15509230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topiramate monotherapy in the treatment of newly or recently diagnosed epilepsy.
    Ben-Menachem E; Sander JW; Stefan H; Schwalen S; Schäuble B
    Clin Ther; 2008 Jul; 30(7):1180-95. PubMed ID: 18691980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.